Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

NCT00149019 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

12

Enrollment

OTHER

Sponsor class

Stopped the PI is no longer work at Hadassah

Conditions

Metastatic Solid Tumors

Interventions

DRUG: Cell therapy with bispecific antibodies

Sponsor

Hadassah Medical Organization